These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31964364)

  • 1. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
    Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
    BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After 18 months of antiretroviral therapy, total HIV DNA decreases more pronouncedly in patients infected by CRF01_AE than in those infected by subtype B and CRF07_BC.
    Lu Z; Jiao Y; Li J; Lan G; Lu C; Li X; Tang Z; Wang N
    Microbiol Immunol; 2018 Apr; 62(4):248-254. PubMed ID: 29377267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
    Ng OT; Lin L; Laeyendecker O; Quinn TC; Sun YJ; Lee CC; Leo YS
    PLoS One; 2011 Jan; 6(1):e15738. PubMed ID: 21298051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study.
    Luo L; Wang N; Yue Y; Han Y; Lv W; Liu Z; Qiu Z; Lu H; Tang X; Zhang T; Zhao M; He Y; Shenghua H; Wang M; Li Y; Huang S; Li Y; Liu J; Tuofu Z; Routy JP; Li T
    BMC Infect Dis; 2019 Mar; 19(1):257. PubMed ID: 30871484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China.
    Cui H; Geng W; Sun H; Han X; An M; Jiang Y; Zhang Z; Chen Z; Xu J; Hu Q; Zhao B; Zhou B; Shang H
    AIDS; 2019 Jan; 33(1):13-22. PubMed ID: 30102662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy.
    Wei L; Li H; Lv X; Zheng C; Li G; Yang Z; Chen L; Han X; Zou H; Gao Y; Cheng J; Wang H; Zhao J
    Retrovirology; 2021 Aug; 18(1):22. PubMed ID: 34399785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts.
    N'takpe JB; Gabillard D; Moh R; Gardiennet E; Emieme A; Badje A; Kouame GM; Toni TD; Karcher S; Carrou JL; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X
    EBioMedicine; 2020 Jun; 56():102815. PubMed ID: 32512517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.
    Oyomopito RA; Li PC; Sungkanuparph S; Phanuphak P; Tee KK; Sirisanthana T; Kantipong P; Oka S; Lee CK; Kamarulzaman A; Choi JY; Sohn AH; Law M; Chen YM;
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):293-300. PubMed ID: 23138836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission.
    Li Y; Han Y; Xie J; Gu L; Li W; Wang H; Lv W; Song X; Li Y; Routy JP; Ishida T; Iwamoto A; Li T;
    AIDS; 2014 Feb; 28(4):521-30. PubMed ID: 24472744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV genetic subtypes and comparison of the first CD(4)(+)T cell counts in newly diagnosed HIV infected patients in Liuzhou, 1998-2012].
    Cao ZQ; Yang WM; Zhu QY; Lan GH; Shen ZY; Liang SS; Li JJ; Chen HH; Feng Y; He X; Liao LJ; Xing H; Ruan YH; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):580-584. PubMed ID: 31177742
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients.
    Bon I; Calza L; Musumeci G; Longo S; Bertoldi A; D'Urbano V; Gibellini D; Magistrelli E; Viale PL; Re MC
    Curr HIV Res; 2017; 15(6):448-455. PubMed ID: 29210661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia.
    Indriati DW; Kotaki T; Khairunisa SQ; Witaningrum AM; Matondang MQY; Ueda S; Nasronudin ; Purnama A; Kurniawan D; Kameoka M
    Curr HIV Res; 2018; 16(2):158-166. PubMed ID: 29732988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study.
    Yue Y; Li Y; Cui Y; Wang N; Huang Y; Cao W; Han Y; Zhu T; Lyu W; Xie J; Song X; Li Y; Wang T; Zhu T; Li T
    BMC Infect Dis; 2021 Jun; 21(1):592. PubMed ID: 34157979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection.
    Ariyoshi K; Matsuda M; Miura H; Tateishi S; Yamada K; Sugiura W
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):336-42. PubMed ID: 12843744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals.
    Li K; Chen H; Li J; Feng Y; Lan G; Liang S; Liu M; Rashid A; Xing H; Shen Z; Shao Y
    Emerg Microbes Infect; 2022 Dec; 11(1):158-167. PubMed ID: 34895083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HIV-1 genetic diversity on disease progression: a prospective cohort study in Guangxi.
    Pang X; Huang J; Tang K; Ma J; Fang N; Xie H; He Q; Zhu Q; Lan G; Liang S
    Front Cell Infect Microbiol; 2024; 14():1415123. PubMed ID: 38994006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of subtypes of pol gene in HIV-1 epidemic strains in Guangxi Zhuang Autonomous Region, 2010- 2012].
    Wang H; Liang B; Zhou B; Jiang J; Huang J; Chen R; Zhao F; Wang M; Liu J; Li W; Ye L; Liang H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):79-84. PubMed ID: 26792508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.